Brief: Titan Pharmaceuticals Says Co Entered Into Securities Purchase Agreement With Certain Accredited Institutional Investors
07/01/2020 22:40
Jan 7 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS - ENTERED INTO SECURITIES PURCHASE
AGREEMENT WITH CERTAIN ACCREDITED INSTITUTIONAL INVESTORS
* TITAN PHARMACEUTICALS- CO TO ISSUE, IN REGISTERED DIRECT
OFFERING & CONCURRENT PRIVATE PLACEMENT, 8.7 MILLION SHARES OF
COMMON STOCK
* TITAN PHARMACEUTICALS - TO ALSO ISSUE WARRANTS TO PURCHASE
8.7
MILLION SHARES OF COMMON STOCK WITH EXERCISE PRICE OF
$0.25/SHARE
Source text: (https://bit.ly/37ElPwe)
Further company coverage: TTNP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.